GlobeNewswire

NRT Technology Completes Acquisition of VisuaLimits, One of the Fastest Growing Gaming Supplier Companies in the US

Dela

Acquisition of VisuaLimits Strengthens NRT's Ability to Connect the Guest Experience(TM) Across the Entire Casino Resort

LAS VEGAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- NRT Technologies, Inc.,  a wholly-owned subsidiary of NRT Technology Corp. (together, "NRT") today announced the successful completion of its acquisition of VisuaLimits, LLC ("VL").   On September 20 2017, NRT and Sightline Payments announced an agreement to merge, with the combined entity to be called NRT Sightline (the "Transaction").  Following close of the Transaction, which remains subject to gaming regulatory approvals, Sightline's CEO and Founder, Kirk Sanford, will assume the role of CEO of NRT Sightline. NRT's current Founder, President and CEO, John Dominelli, will become Chairman of NRT Sightline and will remain active in leading the overall company strategy with a keen focus on driving the technology roadmap.

The acquisition of VL complements NRT's innovative and expansive payment product vision for casinos, which now includes VL's unique 12-in-1 solution.

The VL-Focus and VL-Flex, with their highly adaptive hardware and software, delivers a multitude of services to casino operators and patrons alike, including cashless payments through integration with Sightline's Play+, an HD display for gaming, TV, sports score and advertising messaging, dealer performance (automated hands per hour) and game utilization (automated headcounts), labor savings with time and attendance through Kronos integration, sophisticated surveillance, and 2-way communication functionality which allows dealers to easily contact security, place food and drink orders, and make dinner or club reservation for players.  And because casino operators can easily integrate VL platforms into their existing table rating system, VL offers the added benefit of eliminating the clutter and extra price of redundant hardware. Casino operators can often realize their ROI on VL-Focus and VL-Flex purchases in less than 3 months.

VL's newest product, the VL-EYE, interfaces with the VL-Focus to provide a full surveillance system, including facial, chip, and card recognition capabilities.  Casinos are lining up to be beta sites prior to the VL-EYE's launch next month at G2E. 

"Just in the last year alone VL has tripled its installed base and will finish this year with over 4000 'intelligent' VL-Focus devices, adding some well recognized names to its roster of casino customers, including 8 of the top 10 Global casino operators," said Dominelli.  "And we couldn't be happier with the people that will be joining NRT as part of this acquisition.  They bring a real passion and unparalleled expertise to our organization that will truly enable NRT to Connect the Guest Experience across the entire casino resort."

"The VL platform is like nothing else out there. We deliver actionable insights to operators, delivering tangible business improvements, transactional lift from payments, automated workflows, operational performance improvements and dynamic regulatory compliance. And operators love VL because our solutions consolidate the typical array of table games hardware to de-clutter and improve the overall 'look and feel' of gaming tables," said Ryan McClellan, VL's Co-Founder and former COO who now takes on the role of  SVP Table Game Solutions for NRT.   

"We have received such overwhelmingly positive feedback from operators about the VL product and this, coupled with the excitement of the recently announced VL integration with Sightline's Play+ solution, convinced us that acquiring VL made more sense than continuing under a partnership arrangement," said Michael Dominelli, VP Product and Marketing for NRT.  "Ryan McClellan and his team have built a truly amazing product suite.  The VL platform, along with our slot machine and redemption kiosk integrations, and pending merger with Sightline, will allow the combined entity to provide a frictionless payment experience throughout the entire casino ecosystem."

Financing for the VL acquisition was provided by Fifth Third Bank

About NRT & Sightline

On closing, NRT Sightline(TM) is a global leader in the design and development of enterprise platforms for the casino industry. Every year we enable more than 1 billion physical and digital commerce experiences at over 600 casino properties worldwide.  By seamlessly combining technological innovation with strategic partnerships, we create the most convenient, reliable, and secure omni-channel payment ecosystem for casino operators and their guests. NRT Sightline has been recognized with numerous industry awards, including the coveted "Most Innovative Gaming Technology Product of the Year" for our Play+(TM) cloud-based cashless funding platform. Our solutions are used by casinos, lotteries, race and sports, banking & retailers around the world. We operate across 7 countries and have corporate offices in Las Vegas, Toronto, Macau, and Singapore.

For further information about Sightline or its pending merger with NRT, please contact Omer Sattar, Sightline's EVP Strategic Relationships osattar@sightlinepayments.com.

Sightline's Play+ is patent protected by United States Patent Nos. 8,708,809, 8,777,725, 8,998,708, 9,196,123, 9,245,413, 9,251,651, 9,466,176, 9,

715,785, 9, 715,787 and 9,721,430.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NRT Sightline via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum